Schmidt LE et al. |
Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. |
2003 |
Transplantation |
pmid:12883193
|
Pech T et al. |
Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. |
2012 |
Transplantation |
pmid:22167049
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Burroughs TE et al. |
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. |
2007 |
Transplantation |
pmid:17452891
|
Ciancio G et al. |
Randomized trial of three induction antibodies in kidney transplantation: long-term results. |
2014 |
Transplantation |
pmid:24477186
|
Tzakis AG et al. |
Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation. |
2003 |
Transplantation |
pmid:12717207
|
Méndez A et al. |
Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. |
2014 |
Transplantation |
pmid:24492423
|
Dresske B et al. |
WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation. |
2003 |
Transplantation |
pmid:12717217
|
Eason JD et al. |
Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. |
2003 |
Transplantation |
pmid:12717237
|
Khanna A et al. |
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. |
1998 |
Transplantation |
pmid:9500620
|
Gayowski T et al. |
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. |
1998 |
Transplantation |
pmid:9500623
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Misra S et al. |
Red cell aplasia in children on tacrolimus after liver transplantation. |
1998 |
Transplantation |
pmid:9500636
|
Narayanan M et al. |
Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression. |
2013 |
Transplantation |
pmid:23423268
|
Hougardy JM et al. |
The once-daily formulation of tacrolimus: a step forward in kidney transplantation? |
2012 |
Transplantation |
pmid:22234346
|
Hoffman AL et al. |
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. |
1990 |
Transplantation |
pmid:1690469
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Butani L et al. |
Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. |
2002 |
Transplantation |
pmid:11793001
|
Deuse T et al. |
The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent. |
2004 |
Transplantation |
pmid:15084926
|
Ferraris JR et al. |
Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses. |
2004 |
Transplantation |
pmid:15084930
|
Shapiro R et al. |
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10628763
|
Velidedeoglu E et al. |
Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. |
2004 |
Transplantation |
pmid:15084934
|
Takeguchi N et al. |
Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppressants FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7681229
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Bundick RV et al. |
FK506 as an agonist to induce inhibition of interleukin 2 production. |
1992 |
Transplantation |
pmid:1374947
|
Andrés A et al. |
A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration. |
2009 |
Transplantation |
pmid:19898206
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Winkler ME et al. |
Successful pregnancy in a patient after liver transplantation maintained on FK 506. |
1993 |
Transplantation |
pmid:7506460
|
Suzuki S et al. |
Pure red cell aplasia induced by FK506. |
1996 |
Transplantation |
pmid:8607191
|
Conrotto D et al. |
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. |
2006 |
Transplantation |
pmid:17060865
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Khanna A et al. |
Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. |
1999 |
Transplantation |
pmid:10071036
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Kessler M et al. |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. |
1999 |
Transplantation |
pmid:10071045
|
Hsiau M et al. |
Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation. |
2011 |
Transplantation |
pmid:21857278
|
Yates CJ et al. |
Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. |
2013 |
Transplantation |
pmid:23902993
|
Kitayama T et al. |
Facilitation of tacrolimus-induced heart-allograft acceptability by pretransplant host treatment with granulocyte colony-stimulating factor: interleukin-12-restricted suppression of intragraft monokine mRNA expression. |
2003 |
Transplantation |
pmid:12605126
|
Jiang H et al. |
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. |
2002 |
Transplantation |
pmid:12085006
|
Guo Z et al. |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. |
1997 |
Transplantation |
pmid:9075844
|
Grudé P et al. |
MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. |
2002 |
Transplantation |
pmid:12085008
|
Ciancio G et al. |
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. |
1997 |
Transplantation |
pmid:9075856
|
Xu X et al. |
FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. |
2002 |
Transplantation |
pmid:12085010
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Cooper MH et al. |
Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. |
1994 |
Transplantation |
pmid:7509089
|
Stojanovic J et al. |
Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. |
2017 |
Transplantation |
pmid:27463537
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Lo A et al. |
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation. |
2004 |
Transplantation |
pmid:15114090
|
Jin S et al. |
Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages. |
2004 |
Transplantation |
pmid:15114099
|
Gregory CR et al. |
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. |
1995 |
Transplantation |
pmid:7533955
|
Shoker A et al. |
Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. |
2000 |
Transplantation |
pmid:10949194
|
Egawa H et al. |
Isolated alkaline phosphatemia following pediatric liver transplantation in the FK506 ERA. |
1995 |
Transplantation |
pmid:7533958
|
Straatman LP and Coles JG |
Pediatric utilization of rapamycin for severe cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10949201
|
Sarwal MM et al. |
Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. |
2001 |
Transplantation |
pmid:11468528
|
Burke GW et al. |
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. |
1999 |
Transplantation |
pmid:10573073
|
Nobori S et al. |
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. |
2006 |
Transplantation |
pmid:16421473
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Luan FL et al. |
New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression. |
2011 |
Transplantation |
pmid:21242885
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Suzuki S et al. |
Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. |
1993 |
Transplantation |
pmid:7685932
|
McDiarmid SV et al. |
Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. |
1993 |
Transplantation |
pmid:7685933
|
Ahsan N et al. |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. |
2001 |
Transplantation |
pmid:11477347
|
Moffatt SD et al. |
STAT 6 up-regulation by FK506 in the presence of interleukin-4. |
2000 |
Transplantation |
pmid:10798785
|
Shapiro R et al. |
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. |
2008 |
Transplantation |
pmid:18431232
|
Jugie M et al. |
Study of the impact of liver transplantation on the outcome of intestinal grafts in children. |
2006 |
Transplantation |
pmid:16612274
|
Augustine JJ et al. |
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. |
2006 |
Transplantation |
pmid:16612276
|
Meier M et al. |
Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial. |
2006 |
Transplantation |
pmid:16612281
|
Strumph P et al. |
The effect of FK506 on glycemic response as assessed by the hyperglycemic clamp technique. |
1995 |
Transplantation |
pmid:7542815
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Panz VR et al. |
Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1. |
2002 |
Transplantation |
pmid:11889436
|
Charney DA et al. |
Plasma cell-rich acute renal allograft rejection. |
1999 |
Transplantation |
pmid:10515379
|
Fisher NC et al. |
The clinical impact of nephrotoxicity in liver transplantation. |
2000 |
Transplantation |
pmid:10910259
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
Kessler L et al. |
Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. |
2006 |
Transplantation |
pmid:16495816
|
Chen H et al. |
Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. |
2000 |
Transplantation |
pmid:10836361
|
Moffatt SD and Metcalfe SM |
Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade. |
2000 |
Transplantation |
pmid:10836388
|
Randhawa PS et al. |
Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. |
1999 |
Transplantation |
pmid:9921801
|
Meiser BM |
The best dosing for initial tacrolimus application is trough level adapted! |
2005 |
Transplantation |
pmid:15714162
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Hougardy JM et al. |
Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure. |
2011 |
Transplantation |
pmid:21192316
|
Vanrenterghem Y et al. |
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients. |
2004 |
Transplantation |
pmid:15257032
|
Bayés B et al. |
Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. |
2004 |
Transplantation |
pmid:15257035
|
Arai K et al. |
Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. |
1989 |
Transplantation |
pmid:2479130
|
Miao G et al. |
Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft. |
2004 |
Transplantation |
pmid:15257039
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Mourer JS et al. |
Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients. |
2013 |
Transplantation |
pmid:23715049
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Gaber AO et al. |
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. |
2013 |
Transplantation |
pmid:23715050
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Markus PM et al. |
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. |
1991 |
Transplantation |
pmid:1718063
|
Ryu S and Yasunami Y |
The necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule. |
1991 |
Transplantation |
pmid:1718064
|
Pascher A et al. |
Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation. |
2003 |
Transplantation |
pmid:12923454
|
Hricik DE et al. |
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2003 |
Transplantation |
pmid:14508357
|
Starzl TE et al. |
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. |
1991 |
Transplantation |
pmid:1718068
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
Chan L et al. |
Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients. |
2010 |
Transplantation |
pmid:20517177
|
Hodak SP et al. |
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. |
1998 |
Transplantation |
pmid:9734501
|